These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35249702)

  • 1. SARS-CoV-2 IgG Amongst Dental Workers During the COVID-19 Pandemic.
    Duś-Ilnicka I; Szczygielska A; Kuźniarski A; Szymczak A; Pawlik-Sobecka L; Radwan-Oczko M
    Int Dent J; 2022 Jun; 72(3):353-359. PubMed ID: 35249702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS CoV-2 IgG seropositivity post-vaccination among dental professionals: a prospective study.
    Duś-Ilnicka I; Mazur M; Rybińska A; Radwan-Oczko M; Jurczyszyn K; Paradowska-Stolarz A
    BMC Infect Dis; 2023 Aug; 23(1):539. PubMed ID: 37596519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk indicators of first-wave COVID-19 among oral health-care workers: A French epidemiological survey.
    Jungo S; Moreau N; Mazevet ME; Ejeil AL; Biosse Duplan M; Salmon B; Smail-Faugeron V
    PLoS One; 2021; 16(2):e0246586. PubMed ID: 33571264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
    Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
    JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study.
    Lustig Y; Cohen C; Biber A; Jaber H; Becker Ilany Y; Indenbaum V; Amit S; Mandelboim M; Mendelson E; Regev-Yochay G
    Euro Surveill; 2021 Dec; 26(48):. PubMed ID: 34857065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG.
    Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

  • 9. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
    Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
    Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of SARS-CoV-2 IgG antibodies among dental teams in Germany.
    Mksoud M; Ittermann T; Holtfreter B; Söhnel A; Söhnel C; Welk A; Ulm L; Becker K; Hübner NO; Rau A; Kindler S; Kocher T
    Clin Oral Investig; 2022 May; 26(5):3965-3974. PubMed ID: 35015149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid serological tests for SARS-CoV-2 IgG/IgM - not worth attention?
    Krygier R; Stępień PM; Zarębska-Michaluk D
    Int J Occup Med Environ Health; 2021 May; 34(2):203-209. PubMed ID: 33734216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Opportunity of periodic monitoring of COVID-19 patients, asymptomatic virus carriers, and postinfectious individuals with IgM/IgG rapid antibody tests among healthcare workers during SARS-CoV-2 pandemic].
    Ragó Z; Szijjártó L; Duda E; Bella Z
    Orv Hetil; 2020 May; 161(21):854-860. PubMed ID: 32427569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness and ability of oral health care workers to work during the COVID-19 pandemic.
    Scully AC; Joshi AP; Rector JM; Eckert GJ
    J Am Dent Assoc; 2021 Oct; 152(10):791-799. PubMed ID: 34344507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 in a Fully Operative Dentistry Academic Center in Madrid (Spain) During the De-escalation Phase of the COVID-19 Pandemic. Are Our Dentists at Greater Risk?
    Cintora P; Rojo R; Martínez A; Ruíz B; Aragoneses JM
    Oral Health Prev Dent; 2022 Oct; 20():349-353. PubMed ID: 36259437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Infection among the Dental Staff from Lombardy Region, Italy.
    Gallus S; Paroni L; Re D; Aiuto R; Battaglia DM; Crippa R; Carugo N; Beretta M; Balsano L; Paglia L
    Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33918153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 TEST OUTCOMES AMONG DENTISTS AND DENTAL HYGIENISTS WITH COVID-19-LIKE COMPLAINTS - A RETROSPECTIVE ANALYSIS FROM THE NETHERLANDS.
    Van der Weijden FGA; de Gier B; de Bruin MJC; Valkenburg C; Slot DE
    J Evid Based Dent Pract; 2022 Dec; 22(4):101779. PubMed ID: 36494106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.
    Ocias LF; Skogstam A; Kjerstadius T; Lundin F; Tevell S
    Infect Dis (Lond); 2021; 53(12):920-929. PubMed ID: 34350813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The level of protective post-vaccination antibodies in NIPH-NIH employees after administration of Pfizer vaccine against COVID-19.
    Rastawicki W; Płaza K
    Przegl Epidemiol; 2021; 75(1):3-13. PubMed ID: 34328282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.